Pluripotency and nuclear reprogramming

Annual Review of Biochemistry

Volumn 81, Issue , 2012, Pages 737-765

  Dejosez, Marion ^a   Zwaka, Thomas P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

embryogenesis; epigenetics; stem cells; transcription factors

Indexed keywords

ACTIVIN; ACTIVIN A; BONE MORPHOGENETIC PROTEIN 4; FIBROBLAST GROWTH FACTOR 2; KRUPPEL LIKE FACTOR 2; KRUPPEL LIKE FACTOR 4; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PLATELET DERIVED GROWTH FACTOR; PROTEIN TYROSINE PHOSPHATASE SHP 2; SMAD PROTEIN; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; SOMATOMEDIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 3; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG; WNT PROTEIN;

ARTICLE; BLASTOCYST; BLASTOMERE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL NUCLEUS; CELL PROLIFERATION; CELL RENEWAL; CELL STRUCTURE; CELL TYPE; CHROMATIN STRUCTURE; DEVELOPMENTAL STAGE; DOWN REGULATION; ECTODERM; EMBRYO DEVELOPMENT; EMBRYONAL CARCINOMA STEM CELL; EMBRYONIC GERM CELL; EMBRYONIC STEM CELL; EPIBLAST STEM CELL; EPIGENETICS; HUMAN; IN VITRO STUDY; MULTIPOTENT STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIMORDIUM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TOTIPOTENT STEM CELL; TRANSCRIPTION REGULATION;

ANIMALS; CELL CULTURE TECHNIQUES; EMBRYO, MAMMALIAN; EMBRYONIC STEM CELLS; HUMANS; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELLS;

EID: 84861893874     PISSN: 00664154     EISSN: 15454509     Source Type: Book Series    
DOI: 10.1146/annurev-biochem-052709-104948     Document Type: Article

References (200)

1. Selwood L, Johnson MH. 2006. Trophoblast and hypoblast in the monotreme, marsupial and eutherian mammal: evolution and origins. BioEssays 28(2):128-45
2. BeddingtonRS, Robertson EJ. 1999. Axis development and early asymmetry inmammals. Cell 96(2):195-209
3. Kelly SJ. 1977. Studies of the developmental potential of 4-and 8-cell stage mouse blastomeres. J. Exp. Zool. 200(3):365-76
4. Egli D, Birkhoff G, Eggan K. 2008. Mediators of reprogramming: transcription factors and transitions through mitosis. Nat. Rev. Mol. Cell Biol. 9(7):505-16
5. Johnson MH, Ziomek CA. 1981. The foundation of two distinct cell lineages within the mouse morula. Cell 24(1):71-80
6. Pratt HP, Bolton VN, Gudgeon KA. 1983. The legacy from the oocyte and its role in controlling early development of the mouse embryo. Ciba Found. Symp. 98:197-227
7. Ozawa M, Ringwald M, Kemler R. 1990. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc. Natl. Acad. Sci. USA 87(11):4246-50
8. Nichols J, Smith A. 2009. Naive and primed pluripotent states. Cell Stem Cell 4(6):487-92
9. Hahnel AC, Rappolee DA, Millan JL, Manes T, Ziomek CA, et al. 1990. Two alkaline phosphatase genes are expressed during early development in the mouse embryo. Development 110(2):555-64
10. Gardner RL, Beddington RS. 1988. Multi-lineage 'stem' cells in the mammalian embryo. J. Cell Sci. Suppl. 10:11-27
11. Monk M, Boubelik M, Lehnert S. 1987. Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development 99(3):371-82
12. Hogan BL. 1976. Changes in the behaviour of teratocarcinoma cells cultivated in vitro. Nature 263(5573):136-37
13. Brinster RL. 1974. The effect of cells transferred into the mouse blastocyst on subsequent development. J. Exp. Med. 140(4):1049-56
14. Papaioannou VE, McBurney MW, Gardner RL, Evans MJ. 1975. Fate of teratocarcinoma cells injected into early mouse embryos. Nature 258(5530):70-73
15. Tanaka S, Kunath T, Hadjantonakis AK, Nagy A, Rossant J. 1998. Promotion of trophoblast stem cell proliferation by FGF4. Science 282(5396):2072-75
16. Kunath T, Arnaud D, Uy GD, Okamoto I, Chureau C, et al. 2005. Imprinted X-inactivation in extraembryonic endoderm cell lines from mouse blastocysts. Development 132(7):1649-61
17. Evans MJ, Kaufman MH. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature 292(5819):154-56
18. Martin GR. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78(12):7634-38
19. Smith AG, Heath JK, Donaldson DD, Wong GG, Moreau J, et al. 1988. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336(6200):688-90
20. Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, et al. 1988. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336(6200):684-87
21. Meissner A, Wernig M, Jaenisch R. 2007. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 25(10):1177-81
22. Chazaud C, Yamanaka Y, Pawson T, Rossant J. 2006. Early lineage segregation between epiblast and primitive endoderm in mouse blastocysts through the Grb2-Mapk pathway. Dev. Cell 10(5):615-24
23. Silva J, Smith A. 2008. Capturing pluripotency. Cell 132(4):532-36
24. Tesar PJ, Chenoweth JG, Brook FA, DaviesTJ, Evans EP, et al. 2007. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448(7150):196-99
25. Brons IGM, Smithers LE, Trotter MWB, Rugg-Gunn P, Sun B, et al. 2007. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448(7150):191-95
26. Matsui Y, Zsebo K, Hogan BL. 1992. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 70(5):841-47
27. Resnick JL, Bixler LS, Cheng L, Donovan PJ. 1992. Long-term proliferation of mouse primordial germ cells in culture. Nature 359(6395):550-51
28. Shamblott MJ, Axelman J, Wang S, Bugg EM, Littlefield JW, et al. 1998. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sci. USA 95(23):13726-31
29. Godin I, Deed R, Cooke J, Zsebo K, Dexter M, Wylie CC. 1991. Effects of the steel gene product on mouse primordial germ cells in culture. Nature 352(6338):807-9
30. Surani MA. 1999. Reprogramming a somatic nucleus by trans-modification activity in germ cells. Semin. Cell Dev. Biol. 10(3):273-77
31. Zwaka TP, Thomson JA. 2005. A germ cell origin of embryonic stem cells? Development 132(2):227-33
32. Clark AT, Bodnar MS, Fox M, Rodriquez RT, Abeyta MJ, et al. 2004. Spontaneous differentiation of germ cells from human embryonic stem cells in vitro. Hum. Mol. Genet. 13(7):727-39
33. Hubner K, Fuhrmann G, Christenson LK, Kehler J, Reinbold R, et al. 2003. Derivation of oocytes from mouse embryonic stem cells. Science 300(5623):1251-56
34. GeijsenN, Horoschak M, Kim K, Gribnau J, Eggan K, Daley GQ. 2004. Derivation of embryonic germ cells and male gametes from embryonic stem cells. Nature 427(6970):148-54
35. Kanatsu-Shinohara M, Inoue K, Lee J, Yoshimoto M, OgonukiN, et al. 2004. Generation of pluripotent stem cells from neonatal mouse testis. Cell 119(7):1001-12
36. Guan K, Nayernia K, Maier LS, Wagner S, Dressel R, et al. 2006. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 440(7088):1199-203
37. SeandelM, James D, Shmelkov SV, Falciatori I, Kim J, et al. 2007. Generation of functional multipotent adult stem cells from GPR125+ germline progenitors. Nature 449(7160):346-50
38. Thomson JA, Itskovitz-Eldor J, Shapiro SS, WaknitzMA, Swiergiel JJ, et al. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145-47
39. Dvorak P, DvorakovaD, Koskova S, Vodinska M, Najvirtova M, et al. 2005. Expression and potential role of fibroblast growth factor 2 and its receptors in human embryonic stem cells. Stem Cells 23(8):1200-11
40. Vallier L, Alexander M, Pedersen RA. 2005. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 118(Pt. 19):4495-509
41. Pbay A, Wong RCB, Pitson SM, Wolvetang EJ, Peh GS-L, et al. 2005. Essential roles of sphingosine-1-phosphate and platelet-derived growth factor in themaintenance of human embryonic stem cells. Stem Cells 23(10):1541-48
42. Bendall SC, Stewart MH, Menendez P, George D, Vijayaragavan K, et al. 2007. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448(7157):1015-21
43. Avery S, Inniss K, Moore H. 2006. The regulation of self-renewal in human embryonic stem cells. Stem Cells Dev. 15(5):729-40
44. Vallier L, Mendjan S, Brown S, Chng Z, Teo A, et al. 2009. Activin/Nodal signalling maintains pluripotency by controlling Nanog expression. Development 136(8):1339-49
45. Clark AT, Rodriguez RT, Bodnar MS, Abeyta MJ, CedarsMI, et al. 2004. Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma. Stem Cells 22(2):169-79
46. Guo G, Yang J, Nichols J, Hall JS, Eyres I, et al. 2009. Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 136(7):1063-69
47. Hayashi K, Lopes SMCDS, Tang F, Surani MA. 2008. Dynamic equilibrium and heterogeneity ofmouse pluripotent stem cells with distinct functional and epigenetic states. Cell Stem Cell 3(4):391-401.Int. Stem Cell Initiat.
48. Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, et al. 2007. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat. Biotechnol. 25(7):803-16
49. Babaie Y, Herwig R, Greber B, Brink TC, Wruck W, et al. 2007. Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells 25(2):500-10
50. Assou S, Le Carrour T, Tondeur S, Strm S, Gabelle A, et al. 2007. Ameta-analysis of human embryonic stem cells transcriptome integrated into a Web-based expression atlas. Stem Cells 25(4):961-73
51. Greber B, Wu G, Bernemann C, Joo JY, Han DW, et al. 2010. Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells. Cell Stem Cell 6(3):215-26
52. Tada M, Tada T, Lefebvre L, Barton SC, Surani MA. 1997. Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J. 16(21):6510-20
53. Ying Q-L, Nichols J, Evans EP, Smith AG. 2002. Changing potency by spontaneous fusion. Nature 416(6880):545-48
54. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, et al. 2002. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416(6880):542-45
55. Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T. 2001. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 11(19):1553-58
56. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663-76
57. Ichida JK, Blanchard J, Lam K, Son EY, Chung JE, et al. 2009. A small-molecule inhibitor of Tgf-β signaling replaces Sox2 in reprogramming by inducing Nanog. Cell Stem Cell 5(5):491-503
58. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917-20
59. Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, et al. 2008. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133(2):250-64
60. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, et al. 2009. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458(7239):766-70
61. Carey BW, Markoulaki S, Hanna J, Saha K, Gao Q, et al. 2009. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc. Natl. Acad. Sci. USA 106(1):157-62
62. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. 2008. Induced pluripotent stem cells generated without viral integration. Science 322(5903):945-49
63. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. 2008. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322(5903):949-53
64. Hanna JH, Saha K, Jaenisch R. 2010. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 143(4):508-25
65. Guenther MG, Frampton GM, Soldner F, Hockemeyer D, MitalipovaM, et al. 2010. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7(2):249-57
66. Newman AM, Cooper JB. 2010. Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell 7(2):258-62
67. Kim K, Doi A, Wen B, Ng K, Zhao R, et al. 2010. Epigenetic memory in induced pluripotent stem cells. Nature 467(7313):285-90
68. Falkner FG, Zachau HG. 1984. Correct transcription of an immunoglobulin kappa gene requires an upstream fragment containing conserved sequence elements. Nature 310(5972):71-74
69. Parslow TG, Blair DL, Murphy WJ, Granner DK. 1984. Structure of the 5-ends of immunoglobulin genes: a novel conserved sequence. Proc. Natl. Acad. Sci. USA 81(9):2650-54
70. Herr W, Cleary MA. 1995. The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes Dev. 9(14):1679-93
71. Williams DC Jr, Cai M, Clore GM. 2004. Molecular basis for synergistic transcriptional activation by Oct1 and Sox2 revealed from the solution structure of the 42-kDa Oct1·Sox2·Hoxb1-DNA ternary transcription factor complex. J. Biol. Chem. 279(2):1449-57
72. Lundbck T, Chang JF, Phillips K, Luisi B, Ladbury JE. 2000. Characterization of sequence-specific DNA binding by the transcription factor Oct-1. Biochemistry 39(25):7570-79
73. Phillips K, Luisi B. 2000. The virtuoso of versatility: POU proteins that flex to fit. J. Mol. Biol. 302(5):1023-39
74. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, et al. 1998. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95(3):379-91
75. Niwa H, Miyazaki J, Smith AG. 2000. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24(4):372-76
76. Thomson M, Liu SJ, Zou L-N, Smith Z, Meissner A, Ramanathan S. 2011. Pluripotency factors in embryonic stem cells regulate differentiation into germ layers. Cell 145(6):875-89
77. Kunath T, Saba-El-Leil MK, AlmousailleakhM, Wray J, Meloche S, Smith A. 2007. FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 134(16):2895-902
78. Wang J, Rao S, Chu J, Shen X, Levasseur DN, et al. 2006. A protein interaction network for pluripotency of embryonic stem cells. Nature 444(7117):364-68
79. Van den Berg DLC, Snoek T, Mullin NP, Yates A, Bezstarosti K, et al. 2010. An Oct4-centered protein interaction network in embryonic stem cells. Cell Stem Cell 6(4):369-81
80. Liang J, Wan M, ZhangY, Gu P, Xin H, et al. 2008. Nanog and Oct4 associatewith unique transcriptional repression complexes in embryonic stem cells. Nat. Cell Biol. 10(6):731-79
81. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. 2003. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17(1):126-40
82. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, et al. 2007. Pluripotency governed by SOX2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 9(6):625-35
83. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, et al. 2003. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113(5):631-42
84. Chambers I, Colby D, Robertson M, Nichols J, Lee S, et al. 2003. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113(5):643-55
85. Chambers I, Silva J, Colby D, Nichols J, Nijmeijer B, et al. 2007. Nanog safeguards pluripotency and mediates germline development. Nature 450(7173):1230-34
86. Ivanova N, Dobrin R, Lu R, Kotenko I, Levorse J, et al. 2006. Dissecting self-renewal in stem cells with RNA interference. Nature 442(7102):533-38
87. Wu Q, Chen X, Zhang J, Loh Y-H, Low T-Y, et al. 2006. Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells. J. Biol. Chem. 281(34):24090-94
88. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, et al. 2005. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122(6):947-56
89. Chen X, Xu H, Yuan P, Fang F, Huss M, et al. 2008. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133(6):1106-17
90. Loh Y-H, WuQ, Chew J-L, Vega VB, Zhang W, et al. 2006. TheOct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38(4):431-40
91. Navarro P, Chambers I, Karwacki-Neisius V, Chureau C, Morey C, et al. 2008. Molecular coupling of Xist regulation and pluripotency. Science 321(5896):1693-95
92. Bilodeau S, KageyMH, Frampton GM, Rahl PB, Young RA. 2009. SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state. Genes Dev. 23(21):2484-89
93. Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, et al. 2006. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441(7091):349-53
94. LeeTI, JennerRG, BoyerLA, GuentherMG, Levine SS, et al. 2006. Control of developmental regulators by polycomb in human embryonic stem cells. Cell 125(2):301-13
95. Marson A, Levine SS, Cole MF, FramptonGM, Brambrink T, et al. 2008. ConnectingmicroRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134(3):521-33
96. Pasini D, Bracken AP, Jensen MR, Lazzerini Denchi E, Helin K. 2004. Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J. 23(20):4061-71
97. Eilers M, Eisenman RN. 2008. Myc's broad reach. Genes Dev. 22(20):2755-66
98. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, Dalton S. 2005. LTF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132(5):885-96
99. Smith KN, Lim J-M, Wells L, Dalton S. 2011. Myc orchestrates a regulatory network required for the establishment and maintenance of pluripotency. Cell Cycle 10(4):592-97
100. Smith KN, Singh AM, Dalton S. 2010. Myc represses primitive endoderm differentiation in pluripotent stem cells. Cell Stem Cell 7(3):343-54
101. Kim J, Woo AJ, Chu J, Snow JW, Fujiwara Y, et al. 2010. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 143(2):313-24
102. Lin C-H, Jackson AL, Guo J, Linsley PS, Eisenman RN. 2009. Myc-regulated microRNAs attenuate embryonic stem cell differentiation. EMBO J. 28(20):3157-70
103. Nakamura S, Yokota D, Tan L, Nagata Y, Takemura T, et al. 2012. Down-regulation of Thanatosassociated protein 11 by BCR-ABL promotes CML cell proliferation through c-Myc expression. Int. J. Cancer 130(5):1046-59
104. Zhu C-Y, Li C-Y, Li Y, Zhan Y-Q, Li Y-H, et al. 2009. Cell growth suppression by thanatosassociated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc. Cell Death Differ. 16(3):395-405
105. Dejosez M, Levine SS, Frampton GM, Whyte WA, Stratton SA, et al. 2010. Ronin/Hcf-1 binds to a hyperconserved enhancer element and regulates genes involved in the growth of embryonic stem cells. Genes Dev. 24(14):1479-84
106. Zwaka TP. 2008. Ronin and caspases in embryonic stem cells: a new perspective on regulation of the pluripotent state. Cold Spring Harb. Symp. Quant. Biol. 73:163-69
107. Dejosez M, Krumenacker JS, Zitur LJ, Passeri M, Chu L-F, et al. 2008. Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells. Cell 133(7):1162-74
108. RoussigneM, Kossida S, Lavigne A-C, Clouaire T, Ecochard V, et al. 2003. The THAP domain: a novel protein motif with similarity to the DNA-binding domain of P element transposase. Trends Biochem. Sci. 28(2):66-69
109. Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, et al. 2005. Systematic discovery of regulatory motifs in human promoters and 3 UTRs by comparison of several mammals. Nature 434(7031):338-45
110. Wang D, Manali D, Wang T, Bhat N, Hong N, et al. 2011. Identification of pluripotency genes in the fish medaka. Int. J. Biol. Sci. 7:440-51
111. Walker BA, Leone PE, Chiecchio L, Dickens NJ, JennerMW, et al. 2010. A compendium of myelomaassociated chromosomal copy number abnormalities and their prognostic value. Blood 116(15):e56-65
112. Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, et al. 2010. Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466(7306):632-36
113. Wysocka J, Myers MP, Laherty CD, Eisenman RN, Herr W. 2003. Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1. Genes Dev. 17(7):896-911
114. Capotosti F, Guernier S, Lammers F, Waridel P, Cai Y, et al. 2011. O-GlcNAc transferase catalyzes site-specific proteolysis of HCF-1. Cell 144(3):376-88
115. Nichols J, Chambers I, Taga T, Smith A. 2001. Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. Development 128(12):2333-39
116. Zandstra PW, Le HV, Daley GQ, Griffith LG, Lauffenburger DA. 2000. Leukemia inhibitory factor (LIF) concentration modulates embryonic stem cell self-renewal and differentiation independently of proliferation. Biotechnol. Bioeng. 69(6):607-17
117. Dani C, Chambers I, Johnstone S, Robertson M, Ebrahimi B, et al. 1998. Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway. Dev. Biol. 203(1):149-62
118. Niwa H, Burdon T, Chambers I, Smith A. 1998. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12(13):2048-60
119. Paling NRD, Wheadon H, Bone HK, WelhamMJ. 2004. Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. J. Biol. Chem. 279(46):48063-70
120. Niwa H, Ogawa K, Shimosato D, Adachi K. 2009. A parallel circuit of LIF signalling pathwaysmaintains pluripotency of mouse ES cells. Nature 460(7251):118-22
121. Eiselleova L, Matulka K, Kriz V, Kunova M, Schmidtova Z, et al. 2009. A complex role for FGF-2 in self-renewal, survival, and adhesion of human embryonic stem cells. Stem Cells 27(8):1847-57
122. Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, et al. 2000. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227(2):271-78
123. Xu R-H, Sampsell-Barron TL, Gu F, Root S, Peck RM, et al. 2008. NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 3(2):196-206
124. Levine AJ, Brivanlou AH. 2006. GDF3 at the crossroads of TGF-beta signaling. Cell Cycle 5(10):1069-73
125. Benezra R, Davis RL, LockshonD, TurnerDL, WeintraubH. 1990. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61(1):49-59
126. Tropepe V, Hitoshi S, Sirard C, Mak TW, Rossant J, Van der Kooy D. 2001. Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron 30(1):65-78
127. Ying Y, Qi X, Zhao GQ. 2001. Induction of primordial germ cells from murine epiblasts by synergistic action of BMP4 and BMP8B signaling pathways. Proc. Natl. Acad. Sci. USA 98(14):7858-62
128. Ying QL, Nichols J, Chambers I, Smith A. 2003. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115(3):281-92
129. Suzuki A, Raya A, Kawakami Y, Morita M, Matsui T, et al. 2006. Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells. Proc. Natl. Acad. Sci. USA 103(27):10294-99
130. Qi X, Li T-G, Hao J, Hu J, Wang J, et al. 2004. BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. Proc. Natl. Acad. Sci. USA 101(16):6027-32
131. Itsykson P, Ilouz N, Turetsky T, Goldstein RS, Pera MF, et al. 2005. Derivation of neural precursors from human embryonic stem cells in the presence of noggin. Mol. Cell Neurosci. 30(1):24-36
132. Pera MF, Andrade J, Houssami S, Reubinoff B, Trounson A, et al. 2004. Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. J. Cell Sci. 117(Pt. 7):1269-80
133. Strizzi L, Bianco C, Normanno N, Salomon D. 2005. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis. Oncogene 24(37):5731-41
134. Reynolds D, Vallier L, Chng Z, Pedersen R. 2009. Signaling pathways in embryonic stem cells. In Regulatory Networks in Stem Cells, ed. VK Rajasekhar, MC Vemuri, pp. 293-308. New York: Humana
135. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. 2004. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10(1):55-63
136. Hagen T, Vidal-Puig A. 2002. Characterisation of the phosphorylation of β-catenin at the GSK-3 priming site Ser45. Biochem. Biophys. Res. Commun. 294(2):324-28
137. Mao J, Wang J, Liu B, Pan W, Farr GH 3rd, et al. 2001. Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol. Cell 7(4):801-9
138. Hecht A, Kemler R. 2000. Curbing the nuclear activities of β-catenin. Control over Wnt target gene expression. EMBO Rep. 1(1):24-28
139. Wagner RT, Xu X, Yi F, Merrill BJ, Cooney AJ. 2010. Canonical Wnt/β-catenin regulation of liver receptor homolog-1 mediates pluripotency gene expression. Stem Cells 28(10):1794-804
140. Kelly KF, Ng DY, Jayakumaran G, Wood GA, Koide H, Doble BW. 2011. β-catenin enhances Oct-4 activity and reinforces pluripotency through a TCF-independent mechanism. Cell Stem Cell 8(2):214-27
141. Miki T, Yasuda S-Y, Kahn M. 2011. Wnt/β-catenin signaling in embryonic stem cell self-renewal and somatic cell reprogramming. Stem Cell Rev. 7(4):836-46
142. Rahl PB, Lin CY, Seila AC, Flynn RA, McCuine S, et al. 2010. c-Myc regulates transcriptional pause release. Cell 141(3):432-45
143. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, et al. 2010. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. USA 107(50):21931-36
144. Pan G, Tian S, Nie J, Yang C, Ruotti V, et al. 2007. Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell 1(3):299-312
145. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. 2011. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470(7333):279-83
146. Chen X, Vega VB, Ng H-H. 2008. Transcriptional regulatory networks in embryonic stem cells. Cold Spring Harb. Symp. Quant. Biol. 73:203-9
147. Gaspar-Maia A, Alajem A, Meshorer E, Ramalho-Santos M. 2011. Open chromatin in pluripotency and reprogramming. Nat. Rev. Mol. Cell Biol. 12(1):36-47
148. Meshorer E, Misteli T. 2006. Chromatin in pluripotent embryonic stem cells and differentiation. Nat. Rev. Mol. Cell Biol. 7(7):540-46
149. Young RA. 2011. Control of the embryonic stem cell state. Cell 144(6):940-54
150. Loh Y-H, ZhangW, Chen X, George J, Ng H-H. 2007. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev. 21(20):2545-57
151. Xie L, Pelz C, Wang W, Bashar A, Varlamova O, et al. 2011. KDM5B regulates embryonic stem cell self-renewal and represses cryptic intragenic transcription. EMBO J. 30(8):1473-84
152. Margueron R, Reinberg D. 2011. The Polycomb complex PRC2 and its mark in life. Nature 469(7330):343-49
153. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, et al. 2006. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125(2):315-26
154. Li G, Margueron R, Ku M, Chambon P, Bernstein BE, Reinberg D. 2010. Jarid2 and PRC2, partners in regulating gene expression. Genes Dev. 24(4):368-80
155. Pasini D, Cloos PAC, Walfridsson J, Olsson L, Bukowski J-P, et al. 2010. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 464(7286):306-10
156. Peng JC, Valouev A, Swigut T, Zhang J, Zhao Y, et al. 2009. Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 139(7):1290-302
157. Kaneko S, Li G, Son J, Xu C-F, Margueron R, et al. 2010. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev. 24(23):2615-20
158. Ang Y-S, Tsai S-Y, Lee D-F, Monk J, Su J, et al. 2011. Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell 145(2):183-97
159. JiangH, Shukla A, Wang X, ChenW-y, Bernstein BE, Roeder RG. 2011. Role forDpy-30 in ES cell-fate specification by regulation of H3K4 methylation within bivalent domains. Cell 144(4):513-25
160. Ho L, Crabtree GR. 2010. Chromatin remodelling during development. Nature 463(7280):474-84
161. Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ 3rd. 2002. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev. 16(8):919-32
162. Singhal N, Graumann J, Wu G, Arauzo-Bravo MJ, Han DW, et al. 2010. Chromatin-remodeling components of the BAF complex facilitate reprogramming. Cell 141(6):943-55
163. Lessard JA, Crabtree GR. 2010. Chromatin regulatorymechanisms in pluripotency. Annu. Rev. Cell Dev. Biol. 26:503-32
164. Meissner A. 2010. Epigenetic modifications in pluripotent and differentiated cells. Nat. Biotechnol. 28(10):1079-88
165. Tsumura A, Hayakawa T, Kumaki Y, Takebayashi S, Sakaue M, et al. 2006. Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b. Genes Cells 11(7):805-14
166. Jackson-Grusby L, Jaenisch R. 1996. Experimental manipulation of genomic methylation. Semin. Cancer Biol. 7(5):261-68
167. Stadtfeld M, Maherali N, Breault DT, Hochedlinger K. 2008. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2(3):230-40
168. Pauli A, Rinn JL, Schier AF. 2011. Non-coding RNAs as regulators of embryogenesis. Nat. Rev. Genet. 12(2):136-49
169. Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, et al. 2005. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev. 19(4):489-501
170. MurchisonEP, Partridge JF, TamOH, Cheloufi S, Hannon GJ. 2005. Characterization of dicer-deficient murine embryonic stem cells. Proc. Natl. Acad. Sci. USA 102(34):12135-40
171. Wang Y, Medvid R, Melton C, Jaenisch R, Blelloch R. 2007.DGC8is essential formicroRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat. Genet. 39(3):380-85
172. Melton C, Judson RL, Blelloch R. 2010. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 463(7281):621-26
173. Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS. 2009. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137(4):647-58
174. Helland A, Anglesio MS, George J, Cowin PA, Johnstone CN, et al. 2011. Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers. PLoS ONE 6(4):e18064
175. Judson RL, Babiarz JE, Venere M, Blelloch R. 2009. Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat. Biotechnol. 27(5):459-61
176. SubramanyamD, Lamouille S, Judson RL, Liu JY, Bucay N, et al. 2011. Multiple targets ofmiR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat. Biotechnol. 29(5):443-48
177. Anokye-Danso F, Trivedi CM, Juhr D, GuptaM, Cui Z, et al. 2011. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8(4):376-88
178. Lin S-L, Chang DC, Lin C-H, Ying S-Y, Leu D, Wu DTS. 2011. Regulation of somatic cell reprogramming through inducible mir-302 expression. Nucleic Acids Res. 39(3):1054-65
179. Lin S-L, Chang DC, Ying S-Y, Leu D, WuDTS. 2010. MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of theCDK2and CDK4/6 cell cycle pathways. Cancer Res. 70(22):9473-82
180. Loewer S, Cabili MN, Guttman M, Loh Y-H, Thomas K, et al. 2010. Large intergenic non-coding RNA-RoRmodulates reprogramming of human induced pluripotent stem cells. Nat. Genet. 42(12):1113-17
181. Sheik Mohamed J, Gaughwin PM, Lim B, Robson P, Lipovich L. 2010. Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells. RNA 16(2):324-37
182. Dailey L, Yuan H, Basilico C. 1994. Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer. Mol. Cell. Biol. 14(12):7758-69
183. Balzsi G, Van Oudenaarden A, Collins JJ. 2011. Cellular decision making and biological noise: from microbes to mammals. Cell 144(6):910-25
184. Han DW, Tapia N, Joo JY, Greber B, Arauzo-Bravo MJ, et al. 2010. Epiblast stem cell subpopulations represent mouse embryos of distinct pregastrulation stages. Cell 143(4):617-27
185. Hough SR, Laslett AL, Grimmond SB, Kolle G, Pera MF. 2009. A continuum of cell states spans pluripotency and lineage commitment in human embryonic stem cells. PLoS ONE 4(11):e7708
186. Laslett AL, Grimmond S, Gardiner B, Stamp L, Lin A, et al. 2007. Transcriptional analysis of early lineage commitment in human embryonic stem cells. BMC Dev. Biol. 7:12
187. Bao S, Tang F, Li X, Hayashi K, Gillich A, et al. 2009. Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells. Nature 461(7268):1292-95
188. Niwa H. 2007. How is pluripotency determined and maintained? Development 134(4):635-46
189. Thornberry NA, Lazebnik Y. 1998. Caspases: enemies within. Science 281(5381):1312-16
190. De Maria R, Zeuner A, Eramo A, Domenichelli C, Bonci D, et al. 1999. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 401(6752):489-93
191. Janzen V, Fleming HE, Riedt T, Karlsson G, Riese MJ, et al. 2008. Hematopoietic stem cell responsiveness to exogenous signals is limited by caspase-3. Cell Stem Cell 2(6):584-94
192. Fujita J, Crane AM, SouzaMK, DejosezM, KybaM, et al. 2008. Caspase activity mediates the differentiation of embryonic stem cells. Cell Stem Cell 2(6):595-601
193. Kuida K, Zheng TS, Na S, Kuan C, Yang D, et al. 1996. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384(6607):368-72
194. Zheng TS, Hunot S, Kuida K, Momoi T, Srinivasan A, et al. 2000. Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation. Nat. Med. 6(11):1241-47
195. Li F, He Z, Shen J, Huang Q, Li W, et al. 2010. Apoptotic caspases regulate induction of iPSCs from human fibroblasts. Cell Stem Cell 7(4):508-20
196. Fuhrmann G, Chung AC, Jackson KJ, Hummelke G, Baniahmad A, et al. 2001. Mouse germline restriction of Oct4 expression by germ cell nuclear factor. Dev. Cell 1(3):377-87
197. Gu P, Xu X, Le Menuet D, Chung AC-K, Cooney AJ. 2011. Differential recruitment of methyl CpGbinding domain factors and DNA methyltransferases by the orphan receptor germ cell nuclear factor initiates the repression and silencing of Oct4. Stem Cells 29(7):1041-51
198. Feldman N, Gerson A, Fang J, Li E, Zhang Y, et al. 2006. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol. 8(2):188-94
199. Ben-Shushan E, Sharir H, Pikarsky E, Bergman Y. 1995. A dynamic balance between ARP-1/COUPTFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells. Mol. Cell. Biol. 15(2):1034-48
200. Wray J, Kalkan T, Gomez-Lopez S, Eckardt D, Cook A, et al. 2011. Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nat. Cell Biol. 13(7):838-45